Skip to main content
An official website of the United States government
Email

Funding Opportunities: AI in Cancer Research

NCI funds and supports extramural research to advance the use of AI in cancer research. Find out more about funding opportunities and other ways to engage in advancing AI for cancer research.

AI research is funded through a wide variety of grant and contract programs across NCI, where the majority of cancer research is supported through broad-based, investigator-initiated grant opportunities. The following programs have a strong emphasis on AI:

Specific open Funding Opportunities and Requests for Information are listed in the table below.

TitleAnnouncement NumberOpening DateExpiration DateActivity Code
Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) Development and Testing of Multi-use Frameworks PlaybookRFA-RM-27-011June 30, 2026October 9, 2026U01
Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) Data-to-Model: An Academic-Industrial Partnership (D2M-AIP)RFA-RM-27-012June 30, 2026October 19, 2026UG3/UH3
Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) Model-to-Clinic (M2C)RFA-RM-27-013June 30, 2026October 19, 2026UG3/UH3
Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) Validation CenterRFA-RM-27-014June 30, 2026October 2, 2026U54
Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) Logistics CenterRFA-RM-27-015June 30, 2026October 2, 2026U24
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)RFA-CA-27-019June 1, 2026October 20, 2027U01
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)RFA-CA-27-020June 1, 2026October 20, 2026U24
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)RFA-CA-27-021June 1, 2026October 20, 2026U24
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)PAR-25-079January 5, 2025Jan 7, 2027R01
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01—Clinical Trial Not Allowed)PAR-25-338January 5, 2025January 7, 2028R01
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)PAR-25-321Jan 16, 2025Jan 7, 2028R21
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)PAR-25-346Jan 16, 2025Jan 7, 2028R21
National Science Foundation: Foundations for Digital Twins as Catalyzers of Biomedical Technological Innovation (FDT-BioTech)NSF 24-561March 22, 2024May 4, 2026(see announcement)

 

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Funding Opportunities: AI in Cancer Research was originally published by the National Cancer Institute.”

Email